Ascentage Pharma Group International (AAPG) Other Non-Current Liabilities (2023 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic Other Non-Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $1.1 million.

• Ascentage Pharma Group International's Other Non-Current Liabilities changed N/A to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $860000.0 for FY2024, which is 6678.71% down from last year.
• Ascentage Pharma Group International's Other Non-Current Liabilities amounted to $1.1 million in Q2 2025.
• In the past 5 years, Ascentage Pharma Group International's Other Non-Current Liabilities ranged from a high of $2.5 million in Q4 2023 and a low of $873439.3 during Q4 2024
• Over the past 3 years, Ascentage Pharma Group International's median Other Non-Current Liabilities value was $1.1 million (recorded in 2025), while the average stood at $1.5 million.
• Examining YoY changes over the last 5 years, Ascentage Pharma Group International's Other Non-Current Liabilities showed a top increase of 6563.29% in 2024 and a maximum decrease of 6563.29% in 2024.
• Over the past 3 years, Ascentage Pharma Group International's Other Non-Current Liabilities (Quarter) stood at $2.5 million in 2023, then crashed by 65.63% to $873439.3 in 2024, then increased by 21.14% to $1.1 million in 2025.
• Its last three reported values are $1.1 million in Q2 2025, $873439.3 for Q4 2024, and $2.5 million during Q4 2023.

Peer Comparison